Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System

- June 4th, 2019

Obalon Therapeutics (NASDAQ:OBLN) has announced it has been issued US Patent No. 10,264,995 for its Obalon Navigation System. As quoted in the press release: The first of its kind Obalon Navigation System provides the treating physician with the ability to place the Obalon Balloon without having to incur the costs and inconvenience of utilizing x-ray … Continued

Obalon Therapeutics (NASDAQ:OBLN) has announced it has been issued US Patent No. 10,264,995 for its Obalon Navigation System.

As quoted in the press release:

The first of its kind Obalon Navigation System provides the treating physician with the ability to place the Obalon Balloon without having to incur the costs and inconvenience of utilizing x-ray imaging. The Obalon Navigation System is portable, easy to use, non-invasive, radiation free, and provides dynamic tracking of the Obalon Balloon during placement.

The newly issued patent covers multiple aspects of the Obalon Navigation System, including dynamic tracking using internal and external sensors with an external electromagnetic field.

“We believe this patent provides protection against anyone else entering the market, either with a gas-filled or liquid-filled balloon, that wants to use a similar system to avoid the extra costs and considerable logistics of using x-ray during placement,” said Mark Brister, Obalon’s Chief Technology Officer.

Obalon now has 20 patents issued in the U.S. and 31 patents issued internationally that cover the Obalon Balloon System, with 25 and 55 pending patent applications in the U.S. and in international territories, respectively.

Click here to read the full press release.

Read our new 2019 medical device report today

 

 

Including: 3+ stocks to watch as well as valuable market data   Get My Free Report Click here to download for free

Leave a Reply

Your email address will not be published. Required fields are marked *